Quick answers
- What is Qsymia?
- Qsymia is a brand name of Phentermine and topiramate, a prescription medicine. The FDA NDC Directory lists 4 Qsymia products in 4 strengths and forms.
- Who makes Qsymia?
- Vivus LLC holds the FDA application for Qsymia (NDA022580, approved July 17, 2012).
- Is there a generic or store brand of Qsymia?
- Yes. The FDA NDC Directory lists 8 other products with the same active ingredients, strength and form as a Qsymia product, 8 of them generic. Ask your pharmacist whether one is right for you.
- Has Qsymia been recalled?
- No recall linked to Qsymia products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Qsymia is
Each Qsymia product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Phentermine and topiramate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| phentermine hydrochloride 11.25 mg · topiramate 69 mg capsule, extended release (oral) | Qsymia | 2 products, 2 companies | DailyMed |
| phentermine hydrochloride 15 mg · topiramate 92 mg capsule, extended release (oral) | Qsymia | 2 products, 2 companies | DailyMed |
| phentermine hydrochloride 3.75 mg · topiramate 23 mg capsule, extended release (oral) | Qsymia | 2 products, 2 companies | DailyMed |
| phentermine hydrochloride 7.5 mg · topiramate 46 mg capsule, extended release (oral) | Qsymia | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Phentermine and topiramate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Companies that list Qsymia
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Qsymia products.
- Vivus LLC4 products
Recalls
No recall linked to Qsymia products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.